Compounded drugs as an alternative to the therapeutical gaps of inborn errors of metabolism

Abstract Inborn errors of metabolism are rare disorders with few therapeutic options for their treatments, which can make patients suffer with complications. Therefore, compounded drugs might be a promising option given that they have the ability of meeting the patient's specific needs, (i) identification of the main drugs described in the literature; (ii) proposal of compounding systems and (iii) calculation of the budgetary addition for the inclusion of these drugs into the Brazilian Unified Health System. The research conducted a literature review and used management data as well as data obtained from official Federal District government websites. The study identified 31 drugs for the treatment of inborn errors of metabolism. Fifty eight percent (58%) (18) of the medicines had their current demand identified, which are currently unmet by the local Health System. The estimated budget for the production of compounded drugs was of R$363,16.98 per year for approximately 300 patients. This estimated cost represents a budgetary addition of only 0.17% from the total of expenditures planned for drug acquirement. There is a therapeutic gap for inborn errors of metabolism and compounding pharmacies show potential in ensuring access to medicine therapy with a low-cost investment.

Clinical pharmaceutical services of primary health care of the Federal District: A discussion based on the SWOT matrix

Abstract In the epistemic field, several studies demonstrate the importance of pharmaceutical services in health care networks. Nonetheless, literature still addresses the strengths and barriers present in the provision of these services in an incipient way. Thus, this study aimed to understand these contexts in the development of clinical services for primary health care in the Federal District, Brazil. A qualitative study adopted the technique of open-script interview, structured based on the logic of the SWOT matrix. Pharmacists reported weaknesses such as precariousness and scarcity of physical infrastructure, material, and human resources. As threats, they discussed the lack of social recognition, discontinuities of government actions, and lack of preparation of the pharmacist for the provision of clinical services. Regarding themes pertaining to the service's strengths and opportunities, the advances in propositions and executions of public policies, actions, and governmental programs that have expanded the pharmaceutical workforce in primary care and that are impelling the accomplishment of clinical services were listed. This study contributes to understanding the scenario of the development of clinical pharmaceutical services, and consequently provides subsidies for the actions of planning, evaluation and qualification of health services.

Clinical pharmaceutical services in primary health care of the Federal District: Performance frequency and conditioning factors

Abstract Pharmaceutical services correspond to a set of actions that aim to guarantee the integral access and rational use of drugs by the population. In this sense, this study aimed to identify the frequency and conditioning factors for clinical services of primary care in the Federal District, Brazil. A quantitative cross-sectional study was conducted, in which 34 pharmacists were interviewed. The most frequently developed clinical pharmaceutical services were dispensing, pharmaceutical guidance for users, and technical-pedagogical activities for the health team. There is a greater frequency of operation of clinical services by pharmacists working in pharmacies with physical infrastructure, with better levels of adequacy, greater support from management and health staff, and the inclusion in Family Health Support Nucleus activities. Although the clinical pharmaceutical services in primary care are incipient, the study raises important data for the reorientation and qualification of these actions.

Access and use of medicines by elderly individuals with dementia

The objective is to reveal the difficulties concerning the access and use of medicines by elderly individuals with dementia, reported by their caregivers. This qualitative study applied the participant observation method during pharmaceutical appointments performed in a specialized geriatrics service of the University Hospital of Brasília. Caregivers reported facing difficulties regarding the itinerary for medicines access in public pharmacies, as well as the high cost of these technologies in private establishments. Psychiatric symptoms, cognitive deficits, behavioral changes, apraxia, dysphagia, among other clinical manifestations of dementia syndromes, incapacitates the elderly for self-responsibility concerningthe use of drugs, which accentuates the complexity of medicines administration within the care process. In conclusion, it is fundamental to recognize caregivers' role in promoting the rational use of medicines, and so this theme should be highlighted within the pharmaceutical services context.

Implantação dos serviços clínicos farmacêuticos na atenção primária à saúde do distrito / Implantation of pharmaceutical clinical services in the primary health care of the federal district

Introdução: a implantação dos serviços clínicos farmacêuticos visa qualificar a assistência à saúde da população do DF e está em consonância com as Portarias 77 e 78 de 2017, que estabelecem e regulamentam a Política de Atenção Primária à Saúde do DF.Objetivo: descrever a experiência de implantar os serviços clínicos farmacêuticos no âmbito da Atenção Primária à Saúde do DF.Métodos: o trabalho é descritivo com modalidade de relato de experiência de implantação dos serviços clínicos farmacêuticos, a qual foi organizado em 6 etapas: 1. Seleção das UBS e farmacêuticos; 2. Capacitação dos Farmacêutico; 3. Pactuação com os Gestores regionais e locais; 4. Implantação do serviço, 5. Monitoramento e avaliação dos resultados e 6. Multiplicação para demais UBS.Resultados: capacitação de 100% dos profissionais; a publicação da Nota Técnica nº 2/2017, criada e elaborada em conjunto com os gestores das regiões de saúde, que estabelece os instrumentos para organização do Cuidado Farmacêutico nas Unidades Básicas de Saúde da SES/DF; e serviço clínico executado em 100% das UBS selecionadas.Conclusão: a implantação do cuidado farmacêutico reorganiza a Assistência Farmacêutica, traz resolutividade e qualificação para os serviços de saúde, uma vez que a farmácia passa a prestar serviços clínicos somados aos serviços de logística.

Introduction: The implementation of pharmaceutical clinical services aims to qualify the health care of the population of the Federal District and is in line with Directives 77 and 78 of 2017, which establish and regulate the Primary Health Care Policy of the Federal District.Objective: to describe the experience of implanting pharmaceutical clinical services within the Primary Health Care of the Federal District.Methods: the work is descriptive with experience modality of clinical pharmacy services, which was organized in 6 steps: 1. Selection of PHUs and pharmacists; 2. Pharmacist training; 3. Scheduling with Regional and Local Managers; 4. Implementation of the service, 5. Monitoring and evaluation of results and 6. Multiplication for other UBS.Results: training of 100% of professionals; the publication of Technical Note No. 2/2017, created and elaborated together with the managers of the health regions, which establishes the instruments for the organization of Pharmaceutical Care in the Basic Health Units of SES / DF; and clinical service performed in 100% of the selected UBS.Conclusion: the implementation of pharmaceutical care reorganizes the Pharmaceutical Assistance, brings resolution and qualification to the health services, once the pharmacy starts providing clinical services added to the logistics services.

Pharmaceutical clinical services in basic care in a region of the municipality of São Paulo

Pharmaceutical care has undergone several transformations in the health context over the years. Thus, the pharmacist has suffered a reconfiguration of his performance, mainly with the incorporation of clinical services and patient approach. The study analyzed the results of the implementation of pharmaceutical clinical services in Primary Health Care, through the use of indicators of supply, demand and productivity, clinical and process quality related to pharmaceutical care. We included all the clinical visits (n=1,833) performed to 1,080 users in 12 Basic Health Unit facilities from May to November 2016, of which 40.8% (n=748) were consultations in the establishments and 50.2% (n=1,085) home visits. Most patients (73.5%) were referred by team and 17.5% were captured through active search. Of the total workload, 12.5% ​​were dedicated to pharmaceutical consultations and 20.0% to home visits. In total, we identified 3,078 pharmacotherapy-related issues, an average of 2.8 per patient, and 6,882 pharmaceutical interventions were performed, equivalent to 6.3 interventions per patient. The problem with adherence to pharmacotherapy and the intervention of medication counseling were the most found. Results reinforce the importance of pharmaceutical clinical services in identifying the control of the most prevalent health conditions and monitoring the therapeutic results associated with drug use

Adverse drug reactions among patients admitted with infectious diseases at a Brazilian hospital

Abstract INTRODUCTION: Despite the therapeutic benefits of drugs, adverse drug reactions (ADRs) occur. Method: We assessed a series of suspected ADRs identified from notifications and intensive monitoring of inpatients from March 2013 to March 2014. RESULTS: Skin reactions predominated (31%). Systemic anti-infective agents were implicated in 16 (72%) reactions. Fifteen (68%) ADRs were classified as possible. The implicated drug was not correctly identified by the healthcare team in 12 cases. CONCLUSIONS: Some reactions were not correctly attributed to the causative drug(s), suggesting that the use of a validated evaluation method can promote successful identification of causal links between ADRs and drugs.